1
|
Linder A, Ullrich S, Linder N, Gößmann H, Denecke T, Ebel S. Interventionelle Bergung eines abgerissenen und durch ein
persistierendes Foramen ovale in beide Vorhöfe migrierten
Portkatheters. ROFO-FORTSCHR RONTG 2022. [DOI: 10.1055/s-0042-1756576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- A Linder
- Universitätsklinikum Leipzig, Klinik u. Poliklinik für
Diagnostische u. Interv. Radiologie, Leipzig
| | - S Ullrich
- Klinik und Poliklinik für Diagnostische und Interventionelle
Radiologie, Universitätsklinikum Leipzig, Leipzig
| | - N Linder
- Klinik und Poliklinik für Diagnostische und Interventionelle
Radiologie, Universitätsklinikum Leipzig, Leipzig
| | - H Gößmann
- Klinik und Poliklinik für Diagnostische und Interventionelle
Radiologie, Universitätsklinikum Leipzig, Leipzig
| | - T Denecke
- Klinik und Poliklinik für Diagnostische und Interventionelle
Radiologie, Universitätsklinikum Leipzig, Leipzig
| | - S Ebel
- Klinik und Poliklinik für Diagnostische und Interventionelle
Radiologie, Universitätsklinikum Leipzig, Leipzig
| |
Collapse
|
2
|
Conrad M, Ullrich S, Schmidtke D, Kotz SA. ERPs reveal an iconic relation between sublexical phonology and affective meaning. Cognition 2022; 226:105182. [PMID: 35689874 DOI: 10.1016/j.cognition.2022.105182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2021] [Revised: 05/15/2022] [Accepted: 05/25/2022] [Indexed: 11/03/2022]
Abstract
Classical linguistic theory assumes that formal aspects, like sound, are not internally related to the meaning of words. However, recent research suggests language might code affective meaning such as threat and alert sublexically. Positing affective phonological iconicity as a systematic organization principle of the German lexicon, we calculated sublexical affective values for sub-syllabic phonological word segments from a large-scale affective lexical German database by averaging valence and arousal ratings of all words any phonological segment appears in. We tested word stimuli with either consistent or inconsistent mappings between lexical affective meaning and sublexical affective values (negative-valence/high-arousal vs. neutral-valence/low-arousal) in an EEG visual-lexical-decision task. A mismatch between sublexical and lexical affective values elicited an increased N400 response. These results reveal that systematic affective phonological iconicity - extracted from the lexicon - impacts the extraction of lexical word meaning during reading.
Collapse
Affiliation(s)
- M Conrad
- Department of Cognitive Psychology, Universidad de La Laguna, Spain; Instituto Universitario de Neurociencia (IUNE), Universidad de La Laguna, Spain.
| | | | | | - S A Kotz
- Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany; Maastricht University, Maastricht, the Netherlands
| |
Collapse
|
3
|
Affiliation(s)
- H Mönig
- 3. Med. Klinik, Städtisches Krankenhaus Kiel, Chemnitzstr. 33, 24116, Kiel, Deutschland.
| | - S Ullrich
- 3. Med. Klinik, Städtisches Krankenhaus Kiel, Chemnitzstr. 33, 24116, Kiel, Deutschland
| |
Collapse
|
4
|
Schöffner M, Fichte J, Starl A, Ullrich S, Hopf HB. [Severe respiratory insufficiency as manifestation of a pulmonary metastasized Ewing's sarcoma]. Anaesthesist 2020; 70:223-228. [PMID: 32968844 DOI: 10.1007/s00101-020-00855-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2020] [Revised: 08/28/2020] [Accepted: 09/01/2020] [Indexed: 10/23/2022]
Abstract
A previously unknown tumor led to respiratory failure due to pulmonary metastasis in a young male. The shortness of breath began gradually and then rapidly progressed within 2 weeks. With the cause of respiratory failure still unclear, extracorporeal membrane oxygenation (ECMO) treatment was initiated to gain time for the definitive diagnosis. After the exclusion of infectious lung diseases the diagnosis could be made by a biopsy. Surprisingly, a Ewing's sarcoma was diagnosed and chemotherapy was initiated. This led to tumor regression within about 3 weeks, so that the patient could be successfully weaned from ECMO treatment.
Collapse
Affiliation(s)
- M Schöffner
- Abteilung für Anästhesie, perioperative Medizin und Intensivmedizin, Asklepios Klinik Langen, Röntgenstr. 20, 63225, Langen, Deutschland.
| | - J Fichte
- Abteilung für Anästhesie, perioperative Medizin und Intensivmedizin, Asklepios Klinik Langen, Röntgenstr. 20, 63225, Langen, Deutschland
| | - A Starl
- Abteilung für Anästhesie, perioperative Medizin und Intensivmedizin, Asklepios Klinik Langen, Röntgenstr. 20, 63225, Langen, Deutschland
| | - S Ullrich
- Abteilung für Anästhesie, perioperative Medizin und Intensivmedizin, Asklepios Klinik Langen, Röntgenstr. 20, 63225, Langen, Deutschland
| | - H-B Hopf
- Abteilung für Anästhesie, perioperative Medizin und Intensivmedizin, Asklepios Klinik Langen, Röntgenstr. 20, 63225, Langen, Deutschland
| |
Collapse
|
5
|
Wieder T, Brenner E, Simon N, Bauer J, Gerst F, Ullrich S, Fehrenbacher B, Braumüller H, Röcken M. 023 Senescence surveillance maintains genomic and functional differentiation in pre-malignant tumors. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.07.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
6
|
Wegmann-Herr P, Ullrich S, Durner D. Approaches to limit S-off-flavors during white wine fermentation with specific emphasis on yeast nitrogen nutrition. BIO Web Conf 2019. [DOI: 10.1051/bioconf/20191502029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Low molecular weight volatile sulfur compounds are associated with the “reductive” off flavor of wines. The formation of 15 sulfide off-flavor compounds has been monitored with a novel HS-SPME GC-PFPD method and SIDA quantification during white wine fermentation. Since it is known that glutathione (GSH) might buffer nitrogen stress of the yeast but can also lead to an increase of S-off-flavors, the effect of GSH addition was investigated. Fermentations were carried out in triplicate with Riesling musts showing low NOPA concentrations whereby we evaluated the effect of diammonium hydrogen phosphate (DAHP), pantothenic acid, inactive dry yeast based nutrient (IDY) and must oxidation. It could be shown that only the addition of 0.6 g/L IDY increased fermentation speed and completed fermentations. The addition of IDY as well as GSH lead to a significant increase in H2S formation. Total yeast cells were increased by must oxidation thus leading to faster fermentation whereby no significant difference in S-off-flavors could be observed. The addition of GSH did not affect yeast viability but increased significantly the negative effect of IDY addition regardless the S-off-flavor investigated. In all fermentations the use of DAHP reduced significantly S-off-flavor formation and could completely prevent both S-Methyl thioacetate and S-Ethyl thioacetate development. Under nitrogen deficient conditions, GSH can be used in white wine making when combined with DAHP.
Collapse
|
7
|
Filser M, Schreiber H, Pöttgen J, Ullrich S, Lang M, Penner IK. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): results from the German validation study. J Neurol 2018; 265:2587-2593. [PMID: 30171410 DOI: 10.1007/s00415-018-9034-1] [Citation(s) in RCA: 39] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2018] [Revised: 08/21/2018] [Accepted: 08/22/2018] [Indexed: 10/28/2022]
Abstract
BACKGROUND Recent research has convincingly shown that the ability to work mainly depends on the cognitive status in multiple sclerosis (MS). An international committee of experts recommended a brief neuropsychological battery to evaluate cognitive performance in MS. BICAMS comprises three tests, the Symbol Digit Modalities Test (SDMT), the learning trials of the California Verbal Learning Test II (CVLT-II), and the Brief Visuospatial Memory Test-Revised (BVMT-R). OBJECTIVE To validate BICAMS on a sample of German MS patients and healthy controls (HCs). METHODS According to the international guidelines for validation, examiner's instructions were standardized and translated into German. Due to the availability of better normative data for future applications in routine clinical care and classification of individual performance degree, the Rey Auditory Verbal Learning Test (RAVLT) (German version: Verbaler Lern- und Merkfähigkeits-Test, VLMT) was chosen instead of CVLT-II. 172 MS patients and 100 HCs entered the study. BICAMS was administered at baseline and retest (after 3-4 weeks). RESULTS The groups did not differ in age, gender or education. Mean age of MS patients was 43.33 years (SD 11.64); 68% were female and 86.9% had relapsing-remitting MS. Patients performed significantly worse than HCs on the SDMT (p < 0.01) and on BVMT-R (p < 0.05) but not on VLMT. In addition, BICAMS was shown to be reliable over time: r = 0.71 for BVMT-R, r = 0.72 for VLMT and r = 0.85 for SDMT. SDMT z-score proved to be a good predictor for the ability to work in a full-time (p < 0.001) as well as in a part-time job (p < 0.001). VLMT z-score turned out to be a significant predictor only for the ability to work in a part-time job, while BVMT-R z-score showed no significant predictive value. CONCLUSION In this German validation study with the VLMT, the modified BICAMS (BICAMS-M) turned out to reliably detect cognitive problems in MS patients and to monitor cognitive performance over time. SDMT revealed the best predictive value for working ability. Moreover, only the SDMT was able to predict the ability to work in a part-time or full-time job. Following these results, application of the SDMT is recommended for medical statements on working ability of MS patients.
Collapse
Affiliation(s)
- M Filser
- Cogito Center for Applied Neurocognition and Neuropsychological Research, Düsseldorf, Germany
| | - H Schreiber
- Neurological Practice and Neuropoint Academy, Ulm, Germany
| | - J Pöttgen
- Institut für Neuroimmunologie und Multiple Sklerose, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
| | - S Ullrich
- .05 Statistikberatung, Düsseldorf, Germany
| | - M Lang
- Neurological Practice and Neuropoint Academy, Ulm, Germany
| | - I K Penner
- Cogito Center for Applied Neurocognition and Neuropsychological Research, Düsseldorf, Germany. .,Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
| |
Collapse
|
8
|
Lorza-Gil E, Przemeck GKH, Ulven ER, Sabrautzki S, Panse M, Gerst F, Häring HU, Ulven T, Hrabě de Angelis M, Ullrich S. Role of free fatty acid signaling in islet function. DIABETOL STOFFWECHS 2018. [DOI: 10.1055/s-0038-1641773] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- E Lorza-Gil
- Universitätsklinikum Tübingen, Institut für Diabetes Forschung und Metabolische Krankheiten des Helmholtz Zentrum München an der Universität Tübingen (IDM), Department für Pathophysiologie des Prediabetes, Tübingen, Germany
- German Center for Diabetes Research (DZD e.V.), Tübingen, Germany
| | - GKH Przemeck
- Helmholtz Zentrum München, Institute of Experimental Genetics and the German Mouse Clinic, Neuherberg, Germany
- German Center for Diabetes Research (DZD e.V.), München, Germany
| | - ER Ulven
- University of Southern Denmark, Department of Physics, Chemistry and Pharmacy, Odense M, Denmark
| | - S Sabrautzki
- Helmholtz Zentrum München, Institute of Experimental Genetics and the German Mouse Clinic, Neuherberg, Germany
- Helmholtz Zentrum München, Research Unit Comparative Medicine, Neuherberg, Germany
| | - M Panse
- German Center for Diabetes Research (DZD e.V.), Tübingen, Germany
- University Hospital Tübingen, Internal Medicine IV, Endocrinology, Diabetology, Vascular Medicine, Nephrology and Clinical Chemistry, Tübingen, Germany
| | - F Gerst
- German Center for Diabetes Research (DZD e.V.), Tübingen, Germany
- Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Zentrum München at the University of Tübingen (IDM), Department für Pathophysiologie des Prediabetes, Tübingen, Germany
| | - HU Häring
- German Center for Diabetes Research (DZD e.V.), Tübingen, Germany
- University Hospital Tübingen, Internal Medicine IV, Endocrinology, Diabetology, Vascular Medicine, Nephrology and Clinical Chemistry, Tübingen, Germany
| | - T Ulven
- University of Copenhagen, Department of Drug Design and Pharmacology, Copenhagen, Denmark
| | - M Hrabě de Angelis
- Helmholtz Zentrum München, Institute of Experimental Genetics and the German Mouse Clinic, Neuherberg, Germany
- Technische Universität München, Chair of Experimental Genetics, School of Life Sciences Weihenstephan, München, Germany
| | - S Ullrich
- German Center for Diabetes Research (DZD e.V.), Tübingen, Germany
- Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Zentrum München at the University of Tübingen (IDM), Department für Pathophysiologie des Prediabetes, Tübingen, Germany
| |
Collapse
|
9
|
Lorza-Gil E, Gerst F, Beilmann M, Häring HU, Ullrich S. Improved beta-cell function of human pancreatic microislets. DIABETOL STOFFWECHS 2018. [DOI: 10.1055/s-0038-1641824] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- E Lorza-Gil
- Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Zentrum München at the University of Tübingen (IDM), Tübingen, Germany
- German Center for Diabetes Research (DZD e.V.), Tübingen, Germany
| | - F Gerst
- Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Zentrum München at the University of Tübingen (IDM), Tübingen, Germany
- German Center for Diabetes Research (DZD e.V.), Tübingen, Germany
| | - M Beilmann
- Boehringer Ingelheim Pharma GmbH & Co. KG, Nonclinical Drug Safety, Biberach, Germany
| | - HU Häring
- German Center for Diabetes Research (DZD e.V.), Tübingen, Germany
- University Hospital Tübingen, Internal Medicine IV, Endocrinology, Diabetology, Vascular Medicine, Nephrology and Clinical Chemistry, Tübingen, Germany
| | - S Ullrich
- Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Zentrum München at the University of Tübingen (IDM), Tübingen, Germany
- German Center for Diabetes Research (DZD e.V.), Tübingen, Germany
| |
Collapse
|
10
|
Siegel-Axel D, Jaghutriz BA, Peter A, Machann J, Kovarova M, Ullrich S, Gerst F, Nadalin S, Sipos B, Königsrainer A, Schick F, Stefan N, Fend F, Haen S, Häring HU, Wagner R, Schleicher E. Human fat depots show distinct quantitative, qualitative and functional inter-individual differences. DIABETOL STOFFWECHS 2018. [DOI: 10.1055/s-0038-1641835] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- D Siegel-Axel
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - BA Jaghutriz
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - A Peter
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - J Machann
- Sektion für Experimentelle Radiologie, Abteilung für Diagnostische und Interventionelle Radiologie, Radiologische Klinik, Tübingen, Germany
- Institut für Diabetes-Forschung und Metabolische Erkrankungen (IDM) – Metabolic Imaging des Helmholtz-Zentrums München an der Universität Tübingen, Neuherberg, Germany
| | - M Kovarova
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - S Ullrich
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - F Gerst
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - S Nadalin
- Klinik für Allgemeine, Viszeral- und Transplantationschirurgie, Universitätsklinikum (UKT), Tübingen, Germany
| | - B Sipos
- Klinik für Allgemeine, Viszeral- und Transplantationschirurgie, Universitätsklinikum (UKT), Tübingen, Germany
| | - A Königsrainer
- Klinik für Allgemeine, Viszeral- und Transplantationschirurgie, Universitätsklinikum (UKT), Tübingen, Germany
| | - F Schick
- Sektion für Experimentelle Radiologie, Abteilung für Diagnostische und Interventionelle Radiologie, Radiologische Klinik, Tübingen, Germany
| | - N Stefan
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - F Fend
- Institut für Pathologie und Neuropathologie, Abt. für Allgemeine und Molekulare Pathologie und Pathologische Anatomie, Tübingen, Germany
| | - S Haen
- Institut für Pathologie und Neuropathologie, Abt. für Allgemeine und Molekulare Pathologie und Pathologische Anatomie, Tübingen, Germany
| | - HU Häring
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - R Wagner
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| | - E Schleicher
- Universitätsklinikum Tübingen (UKT), Medizinische Klinik IV, Abt. Endokrinologie, Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz-Zentrums München an der Eberhard-Karls-Universität Tübingen, Neuherberg, Germany
- Deutsches Zentrum für Diabetesforschung (DZD), Tübingen, Germany
| |
Collapse
|
11
|
Jaghutriz BA, Wagner R, Heni M, Gerst F, Siegel-Axel DI, Ullrich S, Lehmann R, Machann J, Stefan N, Häring HU, Fritsche A. Metabolomic characteristics of fatty pancreas. DIABETOL STOFFWECHS 2018. [DOI: 10.1055/s-0038-1641787] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- BA Jaghutriz
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - R Wagner
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - M Heni
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - F Gerst
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - DI Siegel-Axel
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - S Ullrich
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - R Lehmann
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - J Machann
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - N Stefan
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - HU Häring
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - A Fritsche
- Institut für Diabetesforschung und Metabolische Erkrankungen des Helmholtz Zentrum München an der Eberhard-Karls-Universität Tübingen, Tübingen, Germany
- Deutsches Zentrum für Diabetesforschung (DZD e.V.), Tübingen, Germany
- Universitätsklinikum Tübingen, Innere Medizin IV – Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| |
Collapse
|
12
|
Gerst F, Fritz AK, Lorza Gil E, Wolf E, Häring HU, Ullrich S, Kemter E. Fetuin-A impairs maturation of pig neonatal islet cell clusters. DIABETOL STOFFWECHS 2018. [DOI: 10.1055/s-0038-1641768] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- F Gerst
- German Center for Diabetes Research (DZD), Tübingen, Germany
- Helmholtz Zentrum München, Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard-Karls-University of Tuebingen, Tübingen, Germany
- University Hospital Tübingen/Internal Medicine IV, Endocrinology, Diabetology, Angiology, Nephrology und Clinical Chemistry, Tübingen, Germany
| | - AK Fritz
- University Hospital Tübingen/Internal Medicine IV, Endocrinology, Diabetology, Angiology, Nephrology und Clinical Chemistry, Tübingen, Germany
| | - E Lorza Gil
- German Center for Diabetes Research (DZD), Tübingen, Germany
- Helmholtz Zentrum München, Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard-Karls-University of Tuebingen, Tübingen, Germany
- University Hospital Tübingen/Internal Medicine IV, Endocrinology, Diabetology, Angiology, Nephrology und Clinical Chemistry, Tübingen, Germany
| | - E Wolf
- LMU München/Faculty of Veterinary Medicine, Molecular Animal Breeding and Biotechnology, München, Germany
- German Center for Diabetes Research (DZD), München, Germany
| | - HU Häring
- German Center for Diabetes Research (DZD), Tübingen, Germany
- Helmholtz Zentrum München, Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard-Karls-University of Tuebingen, Tübingen, Germany
- University Hospital Tübingen/Internal Medicine IV, Endocrinology, Diabetology, Angiology, Nephrology und Clinical Chemistry, Tübingen, Germany
| | - S Ullrich
- German Center for Diabetes Research (DZD), Tübingen, Germany
- Helmholtz Zentrum München, Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the Eberhard-Karls-University of Tuebingen, Tübingen, Germany
- University Hospital Tübingen/Internal Medicine IV, Endocrinology, Diabetology, Angiology, Nephrology und Clinical Chemistry, Tübingen, Germany
| | - E Kemter
- LMU München/Faculty of Veterinary Medicine, Molecular Animal Breeding and Biotechnology, München, Germany
| |
Collapse
|
13
|
Albersmeier JP, Bremer JP, Dammermann W, Lüth S, Hagenmüller F, Rüther C, Otto H, Nielsen AM, Schumacher U, Ullrich S. Outcome and clinical course of EHEC O104 infection in hospitalized patients: A prospective single center study. PLoS One 2018; 13:e0191544. [PMID: 29420567 PMCID: PMC5805174 DOI: 10.1371/journal.pone.0191544] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2017] [Accepted: 01/08/2018] [Indexed: 12/05/2022] Open
Abstract
Objectives Shiga-toxin producing O157:H7 Entero Haemorrhagic E. coli [STEC/EHEC] are the most common cause of Haemolytic Uraemic Syndrome [HUS] related to infectious haemorrhagic colitis. Nearly all recommendations on long term treatment of EHEC infections refer to this strain. The 2011 outbreak in Northern Europe was the first of this dimension to be caused by the serotype O104:H4. We report on the 3.5 year follow up of 61 patients diagnosed with symptomatic EHEC O104:H4 infection in spring 2011. Methods Patients with EHEC O104 infection were followed in a monocentric, prospective observational study at four time points: 4, 12, 24 and 36 months. These data include the patients’ histories, clinical findings, and complications. Results Sixty-one patients suffering from EHEC O104:H4 associated enterocolitis participated in the study at the time of hospital discharge. The mean age of patients was 43 ± 2 years, 37 females and 24 males. 48 patients participated in follow up 1 [FU 1], 34 patients in follow up 2 [FU 2], 23 patients in follow up 3 [FU 3] and 18 patients in follow up 4 [FU 4]. Out of 61 patients discharged from the hospital and included in the study, 54 [84%] were examined at least at one additional follow up. Serum creatinine decreased significantly between discharge and FU 1 from 1.3 ± 0.1 mg/dl to 0.7 ± 0.1 mg/dl [p = 0.0045]. From FU 1 until FU 4, no further change in creatinine levels could be observed. The patients need of antihypertensive medications decreased significantly [p = 0.0005] between discharge and FU 1 after four months. From FU 1 until FU 3, 24 months later, no further significant change in antihypertensive treatment was observed. Conclusions Our findings suggest that patients free of pathological findings at time of discharge do not need a specific follow up. Patients with persistent health problems at hospital discharge should be clinically monitored over four months to evaluate chronic organ damage. Progressive or new emerging renal damage could not be observed over time in any patient.
Collapse
Affiliation(s)
- J. P. Albersmeier
- Anatomie und Experimentelle Morphologie, Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany
| | - J. P. Bremer
- Abteilung für Rheumatologie und Immunology, Klinikum Bad Bramstedt, Bad Bramstedt, Germany
| | - W. Dammermann
- Center of Internal Medicine II, Brandenburg Medical School, Campus Brandenburg a.d.H., Brandenburg an der Havel, Germany
| | - S. Lüth
- Center of Internal Medicine II, Brandenburg Medical School, Campus Brandenburg a.d.H., Brandenburg an der Havel, Germany
| | - F. Hagenmüller
- I. Medizinische Klinik, Asklepios Klinik Altona, Hamburg, Germany
| | - C. Rüther
- I. Medizinische Klinik, Asklepios Klinik Altona, Hamburg, Germany
| | - H. Otto
- I. Medizinische Klinik, Asklepios Klinik Altona, Hamburg, Germany
| | - A. M. Nielsen
- I. Medizinische Klinik, Asklepios Klinik Altona, Hamburg, Germany
| | - U. Schumacher
- Anatomie und Experimentelle Morphologie, Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany
| | - S. Ullrich
- Anatomie und Experimentelle Morphologie, Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany
- * E-mail:
| |
Collapse
|
14
|
Chen L, Diao L, Yang Y, Yi X, Rodriguez B, Li Y, Rodriguez-Canales J, Liu X, Huang A, Zhao Q, Peng D, Fradette J, Tong P, Ungewiss C, Fan Y, Peng D, Villalobos P, Dmitrovsky E, Papadimitrakopoulou V, Wang J, Byers L, Heymach J, Ullrich S, Wistuba I, Qin X, Gibbons D. OA 13.01 CD38-Mediated Immunometabolic Suppression as a Mechanism of Resistance to PD-1/PD-L1 Axis Blockade. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
15
|
Siegel-Axel DI, Gerst F, Wagner R, Nadalin S, Sipos B, Königsrainer A, Häring HU, Ullrich S. Sind pankreatische Fettzellen anders? Vergleich der Expression inflammatorischer, regenerativer, profibrotischer und Makrophagen-anlockender Faktoren zu Fettzellen verschiedener anderer Lokalisationen im Körper. DIABETOL STOFFWECHS 2017. [DOI: 10.1055/s-0037-1601634] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- DI Siegel-Axel
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - F Gerst
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - R Wagner
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - S Nadalin
- Universitätsklinik für Allgemeine, Viszeral- und Transplantationschirurgie (AVT), Tübingen, Germany
| | - B Sipos
- Universitätsklinik für Allgemeine, Viszeral- und Transplantationschirurgie (AVT), Tübingen, Germany
| | - A Königsrainer
- Universitätsklinik für Allgemeine, Viszeral- und Transplantationschirurgie (AVT), Tübingen, Germany
| | - HU Häring
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| | - S Ullrich
- Medizinische Klinik IV, UKT, Abteilung Endokrinologie und Diabetologie, Angiologie, Nephrologie und Klinische Chemie, Tübingen, Germany
| |
Collapse
|
16
|
Panse M, Gerst F, Kaiser G, Häring HU, Ullrich S. Synergistic effects of palmitate and insulin/IGF-1 signaling on glucose-mediated upregulation of Thioredoxin interacting protein (TxNIP) in pancreatic beta-cells. DIABETOL STOFFWECHS 2017. [DOI: 10.1055/s-0037-1601666] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- M Panse
- German Center for Diabetes Research (DZD), Tübingen, Germany
| | - F Gerst
- German Center for Diabetes Research (DZD), Tübingen, Germany
| | - G Kaiser
- German Center for Diabetes Research (DZD), Tübingen, Germany
| | - HU Häring
- German Center for Diabetes Research (DZD), Tübingen, Germany
| | - S Ullrich
- German Center for Diabetes Research (DZD), Tübingen, Germany
| |
Collapse
|
17
|
Ullrich S, Gerst F, Ullrich A, Häring HU, Lutz SZ. Sunitinib enhances insulin secretion in a glucose- and cAMP/PKA-dependent manner. DIABETOL STOFFWECHS 2017. [DOI: 10.1055/s-0037-1601667] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- S Ullrich
- Helmholtz Zentrum München – Deutsches Forschungszentrum für Umwelt und Gesundheit (GmbH), Institut für Diabetesforschung und Metabolische Krankheiten an der Universität Tübingen, Tübingen, Germany
| | - F Gerst
- Helmholtz Zentrum München – Deutsches Forschungszentrum für Umwelt und Gesundheit (GmbH), Institut für Diabetesforschung und Metabolische Krankheiten an der Universität Tübingen, Tübingen, Germany
| | - A Ullrich
- Max-Planck-Institut für Biochemie, Abteilung Molekularbiologie, Martinsried, Germany
| | - HU Häring
- Helmholtz Zentrum München – Deutsches Forschungszentrum für Umwelt und Gesundheit (GmbH), Institut für Diabetesforschung und Metabolische Krankheiten an der Universität Tübingen, Tübingen, Germany
| | - SZ Lutz
- Helmholtz Zentrum München – Deutsches Forschungszentrum für Umwelt und Gesundheit (GmbH), Institut für Diabetesforschung und Metabolische Krankheiten an der Universität Tübingen, Tübingen, Germany
| |
Collapse
|
18
|
Gerst F, Wagner R, Panse M, Siegel-Axel D, Ordelheide A, Stefan N, Sipos B, Fend F, Nadalin S, Königsrainer A, Häring HU, Ullrich S. Charakterisierung des „fettigen“ Pankreas: Beeinflussen Adipozyten und Immunzellen die Insel? DIABETOL STOFFWECHS 2016. [DOI: 10.1055/s-0036-1580810] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
19
|
Siegel-Axel DI, Gerst F, Panse M, Wagner R, Machann J, Stefan N, Schmidt U, Schreiner B, Sipos B, Fend F, Nadalin S, Königsrainer A, Häring HU, Ullrich S. Interaktionen des „fettigen“ Pankreas mit der Fettleber: Unterschiedliche Effekte von Fetuin-A auf die durch Prädipozyten und Adipozyten vermittelte pankreatische Inflammation. DIABETOL STOFFWECHS 2016. [DOI: 10.1055/s-0036-1580756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
20
|
Ullrich S, Briel D, Nesterko Y, Hiemisch A, Brähler E, Glaesmer H. Verständigung mit Patienten und Eltern mit Migrationshintergrund in der stationären allgemeinpädiatrischen Versorgung. Gesundheitswesen 2016; 78:209-14. [DOI: 10.1055/s-0042-102341] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Affiliation(s)
- S. Ullrich
- Abteilung für Medizinische Psychologie und Medizinische Soziologie, Universitätsklinikum Leipzig AöR
| | - D. Briel
- Abteilung für Medizinische Psychologie und Medizinische Soziologie, Universitätsklinikum Leipzig AöR
| | - Y. Nesterko
- Abteilung für Medizinische Psychologie und Medizinische Soziologie, Universitätsklinikum Leipzig AöR
| | - A. Hiemisch
- Department für Frauen und Kindermedizin, Klinik und Poliklinik für Kinder- und Jugendmedizin, Universitätsklinikum Leipzig AöR
| | - E. Brähler
- Abteilung für Medizinische Psychologie und Medizinische Soziologie, Universitätsklinikum Leipzig AöR
| | - H. Glaesmer
- Abteilung für Medizinische Psychologie und Medizinische Soziologie, Universitätsklinikum Leipzig AöR
| |
Collapse
|
21
|
Widmann F, Bachhuber G, Riedelsheimer A, Schiele A, Ullrich S, Kilian R, Becker T, Frasch K. [Home Treatment]. Fortschr Neurol Psychiatr 2016; 84:42-8; quiz 49. [PMID: 26878432 DOI: 10.1055/s-0041-110887] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
Home Treatment (HT) means acute psychiatric treatment in the patient's usual environment. Conceptually, HT is to be differentiated from other home-based services: It is limited with regard to duration and multiprofessional (e. g. psychiatrist plus psychiatric nursing staff plus social worker); the "24/7"-accessibility is frequently provided by the corresponding background hospital infrastructure. Target group are acutely mentally ill persons with an indication to inpatient treatment, who are willing to cooperate, and absence of endangerment to self and others. In contrast to the Scandinavian and many Anglophone countries where nationwide HT services are delivered, there are not many HT sites in Germany so far. Consequently, empirical data concerning HT in Germany is scarce. In summary, international studies show equivalent effects on psychopathological measures compared to inpatient treatment, reductions with regard to inpatient days, higher patient satisfaction and a trend towards cost-effectivity.
Collapse
|
22
|
Gerst F, Kaiser G, Sartorius T, Stefan N, Häring HU, Ullrich S. TLR2/4 dependent and independent effects of the hepatokine fetuin-A in islets. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0035-1549528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
23
|
Panse M, Gerst F, Kaiser G, Häring HU, Ullrich S. The role of FOXO1 in palmitate-induced β-cell death. DIABETOL STOFFWECHS 2015. [DOI: 10.1055/s-0035-1549756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
24
|
Schönecker S, Kraushaar U, Guenther E, Gerst F, Ullrich S, Häring HU, Königsrainer A, Barthlen W, Drews G, Krippeit-Drews P. Human Islets Exhibit Electrical Activity on Microelectrode Arrays (MEA). Exp Clin Endocrinol Diabetes 2015; 123:296-8. [DOI: 10.1055/s-0035-1547217] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- S. Schönecker
- Department of Electrophysiology, NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen
| | - U. Kraushaar
- Department of Electrophysiology, NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen
| | - E. Guenther
- Department of Electrophysiology, NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen
| | - F. Gerst
- Division of Endocrinology, Department of Internal Medicine and IDM, Diabetology, Vascular Medicine, Nephrology, and Clinical Chemistry, University of Tübingen
| | - S. Ullrich
- Division of Endocrinology, Department of Internal Medicine and IDM, Diabetology, Vascular Medicine, Nephrology, and Clinical Chemistry, University of Tübingen
| | - H.-U. Häring
- Division of Endocrinology, Department of Internal Medicine and IDM, Diabetology, Vascular Medicine, Nephrology, and Clinical Chemistry, University of Tübingen
| | - A. Königsrainer
- Department of General, Visceral and Transplant Surgery, University Hospital, Tübingen
| | - W. Barthlen
- Department of Pediatric Surgery, University Medicine Greifswald, Germany
| | - G. Drews
- Department of Pharmacology, Institute of Pharmacy, University of Tübingen
| | - P. Krippeit-Drews
- Department of Pharmacology, Institute of Pharmacy, University of Tübingen
| |
Collapse
|
25
|
Wagner R, Heni M, Hatziagelaki E, Stefan N, Ullrich S, Machicao F, Häring HU, Fritsche A. Peroxisome proliferator-activated receptor gamma (PPARG) moduliert die Insulinsekretion über den Fettsäurerezeptor FFAR1. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1375049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
26
|
Gerst F, Kaiser G, Panse M, Pujol A, Bosch F, Häring HU, Ullrich S. PKCdelta-dependent phosphorylation of 14 – 3-3zeta delays the nuclear export of FOXO1 in beta-cells. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1374924] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
27
|
Kaiser G, Gerst F, Ullrich S, Häring HU, Przemeck G, Sabrautzki S, Hrabĕ de Angelis M. Mice with point mutations in Ffar1 display impaired glucose tolerance. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1374877] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
28
|
Panse M, Kaiser G, Gerst F, Häring HU, Ullrich S. Regulation of thioredoxin interacting protein by FFA1 ligands under hyperglycemic conditions. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1374963] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
29
|
Kaiser G, Gerst F, Stefan N, Ullrich S, Haering HU. The hepatokine fetuin-A associates with insulin resistance and induces inflammation but selectively improves cAMP-dependent insulin secretion of human islets. Exp Clin Endocrinol Diabetes 2014. [DOI: 10.1055/s-0034-1371988] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
30
|
Kaiser G, Gerst F, Michael D, Berchtold S, Friedrich B, Strutz-Seebohm N, Lang F, Häring HU, Ullrich S. Regulation of forkhead box O1 (FOXO1) by protein kinase B and glucocorticoids: different mechanisms of induction of beta cell death in vitro. Diabetologia 2013; 56:1587-95. [PMID: 23435785 DOI: 10.1007/s00125-013-2863-7] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/21/2012] [Accepted: 01/29/2013] [Indexed: 10/27/2022]
Abstract
AIMS/HYPOTHESIS In steroid diabetes insulin secretion does not adequately compensate for enhanced hepatic gluconeogenesis and peripheral insulin resistance. Previous studies suggest that activation of the transcription factor forkhead box O1 (FOXO1) contributes to glucocorticoid-induced beta cell death. This study examines the role and regulation of FOXO1 in insulin-secreting cells. METHODS INS-1E cells and mouse islet cells were cultured in the presence of dexamethasone. Signalling pathways were modified pharmacologically or by small interfering (si)RNA-mediated inhibition of protein synthesis. Changes in protein abundance and phosphorylation were analysed by western blotting, and subcellular localisation was assessed using confocal microscopy. Transcript levels were examined by RT-PCR. RESULTS Surprisingly, downregulation of FOXO1 by siRNA did not affect dexamethasone-induced apoptosis or Bim expression, but it prevented the effects of the pan protein kinase B (AKT) inhibitor (Akti-1/2). Indeed, dexamethasone and Akti-1/2 synergistically increased beta cell death and Bim expression. Akti-1/2 triggered dephosphorylation and nuclear translocation of FOXO1. Glucocorticoid-receptor activation stimulated Foxo1 transcription, but FOXO1 phosphorylation was unchanged and the cytosolic concentration of FOXO1 remained high in relation to its nuclear concentration. However, subcellular fractionation revealed a significant increase in both cytosolic and nuclear FOXO1 compared with untreated cells. Dexamethasone diminished Pdx1 mRNA level, an effect which was not reversed by siRNA against Foxo1. Downregulation of AKT isoforms and serum/glucocorticoid-regulated kinase 1 (SGK1) suggests that only sustained suppression of all three AKT isoforms caused dephosphorylation and nuclear accumulation of FOXO1. CONCLUSIONS/INTERPRETATION This study reveals that FOXO1 is not the main mediator of glucocorticoid-receptor-induced beta cell apoptosis, but rather that it escalates beta cell death when AKT activity is inhibited by distinct pathways.
Collapse
Affiliation(s)
- G Kaiser
- Division of Endocrinology, Diabetology, Vascular Medicine, Nephrology and Clinical Chemistry, Department of Internal Medicine IV, University of Tübingen, Otfried-Müller-Strasse 10, 72076, Tübingen, Germany
| | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Larpent A, Davidson-Park B, McCallum S, Price K, Evans D, Ullrich S, Williamson P. LIVING WELL DYING WELL: PUTTING THESE WORDS INTO ACTION. BMJ Support Palliat Care 2013. [DOI: 10.1136/bmjspcare-2013-000491.73] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
32
|
Ullrich S, Kesel N, Schumacher U, Gross W, Laudien M, Müller A, Holl-Ulrich K. THU0040 Histology of nasal tissue destruction in GPA patients is reflected in human tissue transplants of GPA patients in immunodeficient mice. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.2005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
33
|
Kaiser G, Teutsch CA, Gerst F, Häring HU, Ullrich S. Die Rolle des MAPK Signalweges bei der Palmitinsäure-induzierten Insulinsekretion und dem apoptotischen Beta-Zelltod. DIABETOL STOFFWECHS 2013. [DOI: 10.1055/s-0033-1341714] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
34
|
Gerst F, Wagner R, Keiser G, Christiansen E, Due-Hansen ME, Machicao F, Peter A, Trond U, Fritsche A, Häring HU, Ullrich S. Die Rolle des Fettsäurerezeptor 1 (FFAR1/GPR40) in insulinsezernierenden Zellen. DIABETOL STOFFWECHS 2013. [DOI: 10.1055/s-0033-1341690] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
35
|
Ullrich S, Yu H, Evans NL. Sigma*-mediated electronic relaxation in 200nm photoexcited ammonia and heteroaromatics. EPJ Web of Conferences 2013. [DOI: 10.1051/epjconf/20134102032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
36
|
Ordelheide AM, Machicao F, Ullrich S, Stefan N, Fritsche A, Häring HU, Staiger H. Nor-1 ist ein neuer Regulator von Insulingenen und spielt eine Rolle bei der Insulinsekretion. DIABETOL STOFFWECHS 2012. [DOI: 10.1055/s-0032-1314433] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
37
|
Schulz-Raffelt G, Ranta F, Häring HU, Ullrich S. Palmitat beeinflusst differentiell Insulin/IGF-1 Rezeptor Signalwege. Wechselwirkungen zwischen PKB/AKT, PKCdelta und MAPK. DIABETOL STOFFWECHS 2012. [DOI: 10.1055/s-0032-1314535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
38
|
Schulz-Raffel G, Michael D, Berchtold S, Ranta F, Häring HU, Ullrich S. Regulation des Transkriptionsfaktors FOXO1 durch AKT1, AKT2 und SGK1 in insulinsezernierenden Zellen. DIABETOL STOFFWECHS 2011. [DOI: 10.1055/s-0031-1277463] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
39
|
Ullrich S, Schmidt J, Merten N, Grundmann M, Mielenz M, Sauerwein H, Christiansen E, Due-Hansen ME, Ulven T, Gomeza J, Drewke C, Häring HU, Kostenis E. Konjugierte Linolsäuren stimulieren die Insulinsekretion über den Fettsäurerezeptor FFA1. DIABETOL STOFFWECHS 2011. [DOI: 10.1055/s-0031-1277373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
40
|
Salamon J, Ramos Leal N, Peldschus K, Ittrich H, Schumacher U, Adam G, Ullrich S, Wicklein D. Sequentielle MRT-Untersuchungen und Durchflusszytometrie zur Kontrolle der Therapie mit Imatinib in einem neuen Xenograft-Modell der humanen Chronischen Eosinophilen Leukämie (CEL). ROFO-FORTSCHR RONTG 2011. [DOI: 10.1055/s-0031-1279408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
41
|
Wicklein D, Ramos-Leal N, Peldschus K, Salamon J, Schumacher U, Ullrich S. Quantifizierung von Tumorlast und Effektivität der Imatinib Behandlung in einem Xenograft Modell für humane Chronische Eosinophile Leukämie mittel MRI und Durchflusszytometrie. ROFO-FORTSCHR RONTG 2010. [DOI: 10.1055/s-0030-1268307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
42
|
Pfleiderer M, Liebscher K, Ranta F, Noack K, Drews G, Christiansen E, Ulven T, Häring HU, Ullrich S. Effekte neuer Fettsäure-Rezeptor-Agonisten in insulinsezernierenden Zellen. DIABETOL STOFFWECHS 2010. [DOI: 10.1055/s-0030-1253989] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
43
|
Theilig D, Leveringhaus J, Ranta F, Handrick R, Jendrossek V, Lammers R, Häring HU, Ullrich S. Regulation der Proliferation Insulin-sezernierender Zellen durch PKCδ. DIABETOL STOFFWECHS 2010. [DOI: 10.1055/s-0030-1253990] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
44
|
Hoffmann-Castendiek B, Ullrich S, Welte T. Vergleichsanalyse von Frauen und Männern mit Verdachtsdiagnose SAS bei Erstvorstellung mit PSG im Schlaflabor – Erste Ergebnisse eine prospektiven Verlaufsstudie. Pneumologie 2010. [DOI: 10.1055/s-0030-1251259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
45
|
Grottke O, Ntouba A, Ullrich S, Liao W, Fried E, Prescher A, Deserno T, Kuhlen T, Rossaint R. Virtual reality-based simulator for training in regional anaesthesia. Br J Anaesth 2009; 103:594-600. [DOI: 10.1093/bja/aep224] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
46
|
Coid J, Yang M, Bebbington P, Moran P, Brugha T, Jenkins R, Farrell M, Singleton N, Ullrich S. Borderline personality disorder: health service use and social functioning among a national household population. Psychol Med 2009; 39:1721-1731. [PMID: 19250579 DOI: 10.1017/s0033291708004911] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND It is unclear whether Axis II psychopathology or co-morbid clinical syndromes result in the treatment-seeking behaviour and social impairment of patients with borderline personality disorder (BPD). This study examined the independent associations between social functioning and service use and Axis I and Axis II disorders in persons with BPD in the national household population of Britain. METHOD The study was a cross-sectional survey of adults aged 16-74 years in households (n=8397). Data included self-reported consultations with health-care professionals and behavioural problems. Diagnosis was determined by computer-assisted interviews. Analyses included logistic regression adjusting for demography, co-morbid Axis I clinical syndromes and other Axis II disorders. RESULTS Consultation in the past year was reported by 57.5% of persons with BPD but only 13.4% reported lifetime psychiatric admission. BPD was not independently associated with impaired functioning but was associated with co-morbid psychotic, depressive and anxiety disorders. Only general practitioners (GPs) were consulted for problems independently due to BPD. CONCLUSIONS Functional effects of BPD are mediated through co-morbid clinical syndromes, not Axis II psychopathology. A subgroup do not have co-morbid disorders or seek treatment, and are high functioning.
Collapse
Affiliation(s)
- J Coid
- University of London, UK.
| | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Ullrich S, Gustke H, Lamprecht P, Gross WL, Schumacher U, Ambrosch P, Laudien M. Severe impaired respiratory ciliary function in Wegener granulomatosis. Ann Rheum Dis 2008; 68:1067-71. [PMID: 19028765 DOI: 10.1136/ard.2008.096974] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
OBJECTIVE The pathogenesis of granulomatous inflammation in the respiratory tract and autoimmunity in Wegener granulomatosis (WG) are poorly understood. Since mucociliar clearance represents the first major line of defence in the respiratory tract and its breakdown facilitates chronic inflammation, we investigated ciliary beat frequency (CBF) in WG. METHODS Nasal epithelial cells were obtained from 30 patients with WG with involvement of the upper respiratory tract, 12 patients with other inflammatory rheumatic disease and 10 healthy controls. CBF was measured at 5 and 24 h after collection. RESULTS were correlated with clinical data. Results: CBF was significantly reduced in WG compared to disease and healthy controls after 5 and 24 h. In WG, CBF almost stagnated after 24 h. Reduction of CBF correlated with the cumulative number of immunosuppressive agents in WG, but not in disease controls. No correlation was found between CBF impairment and cyclophosphamide levels, disease extent, disease activity, disease duration, serological and microbiological findings, or inflammation markers. CONCLUSION CBF is severely impaired in WG, potentially influenced by immunosuppressive treatment. To what extent CBF impairment and subsequent barrier dysfunction are caused by other factors still has to be elucidated. Supportive measures to improve mucociliary clearance should be discussed in patients with WG.
Collapse
Affiliation(s)
- S Ullrich
- Department for Anatomy II, Experimental Morphologie, University Medical Center Hamburg-Eppendorf, Germany.
| | | | | | | | | | | | | |
Collapse
|
48
|
Sodeur S, Ullrich S, Gustke H, Zangemeister-Wittke U, Schumacher U. Increase of spontaneous lung metastasis of small cell lung cancer in the absence of Natural Killer cells in Pfp/Rag2 double knock out mice. Pneumologie 2008. [DOI: 10.1055/s-2008-1074188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
49
|
Ullrich S, Gustke H, Schumacher U, Lamprecht P, Gross W, Gottschlich S, Laudien M. Verminderter Zilienschlag bei Patienten mit Wegener'scher Granulomatose: Folge der Erkrankung oder der Therapie? Pneumologie 2008. [DOI: 10.1055/s-2008-1074436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
50
|
Plitz O, Hagena F, Ullrich S. Ein Fingerergometer als neue Möglichkeit zur Objektivierung der Handfunktion. AKTUEL RHEUMATOL 2008. [DOI: 10.1055/s-2008-1047399] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|